financetom
Business
financetom
/
Business
/
CVS Health's Q1 Adjusted Earnings, Revenue Rise; Raises 2025 Adjusted EPS Guidance
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CVS Health's Q1 Adjusted Earnings, Revenue Rise; Raises 2025 Adjusted EPS Guidance
May 25, 2025 11:08 PM

06:49 AM EDT, 05/01/2025 (MT Newswires) -- CVS Health ( CVS ) reported Q1 adjusted earnings Thursday of $2.25 per diluted share, up from $1.31 a year earlier.

Analysts polled by FactSet expected $1.70.

Revenue for the quarter ended March 31 was $94.59 billion, compared with $88.44 billion a year earlier.

Analysts surveyed by FactSet expected $93.66 billion.

For 2025, the company raised its adjusted EPS guidance range to now be $6 to $6.20 from the prior outlook of $5.75 to $6. Analysts surveyed by FactSet expect $5.92.

Shares of the company rose more than 6% in premarket activity.

Price: 71.29, Change: +4.59, Percent Change: +6.88

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Accenture Tempers Fiscal 2024 Topline Growth Guidance as Second-Quarter Revenue Misses Views
Accenture Tempers Fiscal 2024 Topline Growth Guidance as Second-Quarter Revenue Misses Views
Mar 21, 2024
10:22 AM EDT, 03/21/2024 (MT Newswires) -- Accenture ( ACN ) on Thursday lowered its full-year revenue growth outlook amid macroeconomic uncertainties as the consulting firm's fiscal second-quarter sales fell short of market expectations. The company expects revenue to increase by 1% to 3% in local currency for fiscal 2024, compared with its previous guidance for a 2% to 5%...
Salesforce Insider Sold Shares Worth $4,493,875, According to a Recent SEC Filing
Salesforce Insider Sold Shares Worth $4,493,875, According to a Recent SEC Filing
Mar 21, 2024
10:24 AM EDT, 03/21/2024 (MT Newswires) -- Marc Benioff, Director, Chair and CEO, on March 19, 2024, sold 15,000 shares in Salesforce ( CRM ) for $4,493,875. Following the Form 4 filing with the SEC, Benioff has control over a total of 23,131,166 shares of the company, with 13,131,166 shares held directly and 10,000,000 shares controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1108524/000112760224010771/xslF345X03/form4.xml...
Aerovate Therapeutics Insider Sold Shares Worth $908,046, According to a Recent SEC Filing
Aerovate Therapeutics Insider Sold Shares Worth $908,046, According to a Recent SEC Filing
Mar 21, 2024
10:24 AM EDT, 03/21/2024 (MT Newswires) -- Benjamin T Dake, President, Chief Operating Officer and Secretary, on March 18, 2024, sold 35,057 shares in Aerovate Therapeutics ( AVTE ) for $908,046. Following the Form 4 filing with the SEC, Dake has control over a total of 1,291 shares of the company, with 1,291 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1798749/000141588924008770/xslF345X03/form4-03202024_060307.xml Price:...
Meta Platforms Insider Sold Shares Worth $15,443,338, According to a Recent SEC Filing
Meta Platforms Insider Sold Shares Worth $15,443,338, According to a Recent SEC Filing
Mar 21, 2024
10:23 AM EDT, 03/21/2024 (MT Newswires) -- Mark Zuckerberg, 10% Owner, Director, Chairman of Board and CEO, on March 19, 2024, sold 31,493 shares in Meta Platforms ( META ) for $15,443,338. Following the Form 4 filing with the SEC, Zuckerberg has control over a total of 320,000 shares of the company, with 320,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1326801/000095010324004092/xslF345X03/dp208606-zuckerberg0319ii.xml Price:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved